2 withdrawn, 1 completed, 1 terminated. 4 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Withdrawn 2, Completed 1, Terminated 1 |
| Phase 1 | 2 | Terminated 1, Withdrawn 1 |
Follow ExoFlo: new trials by email Literature Review of ExoFlo trials Research Report on ExoFlo
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles Infusion Treatment for ARDS Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles, Saline - ARDS, Human | Phase 1 / Phase 2 | Withdrawn | Direct Biologics, LLC | 2024-12-01 | 2024-07-29 | |
| Study of ExoFlo for the Treatment of Perianal Fistulas ExoFlo, Local injection of normal saline - Perianal Fistula, Crohn's Disease | Phase 1 / Phase 2 | Terminated | Direct Biologics, LLC | 5 | 2023-08-28 | 2026-08-11 |
| Extracellular Vesicles Infusion Treatment for Mild-to-Moderate COVID-19 ExoFlo - COVID-19 | Phase 2 | Withdrawn | Direct Biologics, LLC | 2022-12-07 | 2024-02-13 | |
| Extracellular Vesicle Infusion Treatment for COVID-19 Associated ARDS ExoFlo, Intravenous normal saline - COVID-19, ARDS | Phase 2 | Completed | Direct Biologics, LLC | 102 | 2020-09-24 | 2024-02-13 |
COVID-19 (2) · Crohn Disease (1) · Lymphoma, Follicular (1) · Respiratory Distress Syndrome (1)
United States (2)
Bill Arana (4)